Immutep Abstract on IMP761 Accepted for ACR Poster Presentation
The late-breaking poster will present data from the first-in-human Phase I study of IMP761 in healthy volunteers.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Immutep abstract accepted for ACR Convergence 2026 poster presentation
Immutep says its late-breaking abstract on IMP761 was accepted for poster presentation at ACR Convergence 2026.